MARKETSQUIET
17 days ago
'A breakthrough in saving lives': Cizzle's blood test for lung cancer accredited for clinical use in US
What's happening
SignalsMonitor is following this as a markets story. Yorkshire Post is the outlet attached so far. The first report grouped here was at 30 Sept 2026, 10:30 UTC. The headline in use is “'A breakthrough in saving lives': Cizzle's blood test for lung cancer accredited for clinical use in US”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
York-based Cizzle Biotechnology Holdings has reported on a “landmark” half year in which its blood test for lung cancer was successfully accredited for clinical use in the US, the world’s largest diagnostics market.
Yorkshire PostRead at Yorkshire Post
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by Yorkshire Post
Reported by 1 outlet
- Yorkshire Post